I want to be transparent with you, because in the wellness category transparency is both a value and, increasingly, a compliance exposure, and I like to hold the two in the same hand.
I have spent my career acquiring things that cannot be built, and I want to talk about the hardest one. Not a factory. Not a patent. Not a distribution agreement. Those are buildable; they are line items with lead times. The asset I mean is trust, and trust is the only input in this category that a large company is structurally incapable of manufacturing.
Here is the uncomfortable math, stated plainly. A conglomerate operates at a cost of capital that assumes a return on a schedule. Trust does not accrue on a schedule. It accrues the way a founder accrues it: standing behind a folding table at a natural-products expo in 1997, answering a skeptical shopper's question about where the turmeric was sourced, and then being right, quietly, for twenty years, one honest label at a time. You cannot buy that shopper's belief with a media budget. The belief is not for sale.
The brand the shopper believes in, however, is very much for sale. And that is the entire thesis of the modern wellness portfolio.
We call the discipline Trust Acquisition, and the reference architecture, internally, is DECANT — because the goal is to pour a credibility that was aged, slowly, in an independent brand into the margin structure of a company that could never have fermented it in-house. You do not disturb the sediment. You do not tell the bottle it has been moved. You decant.
The Category Nobody Trusts, and the Exceptions That Prove It
I want to start where the retail-facing view starts, because the person at the shelf sees this most clearly of all.
The American supplements aisle is a low-trust environment by default. The customer standing in front of it has been told, correctly, that the category is under-regulated, that claims outrun evidence, that the pill may not contain what the label says. That customer is a skeptic before they pick anything up. This is the ground state.
Against that ground state, a small number of independent brands did something remarkable: they earned belief. New Chapter earned it with an unbending commitment to organic, non-GMO whole-food formulation out of Brattleboro, Vermont. Garden of Life earned it as the brand the raw-foods and clean-label crowd would actually defend by name. Solgar earned it across decades as the one the naturopath recommended. Nature's Bounty earned it as the bottle a grandmother trusted. Each of these was, in the exact sense that matters, an exception to the customer's default distrust.
Now, from a portfolio standpoint, contemplate what an exception to distrust is worth in a category defined by distrust. It is not worth its revenue. It is worth its revenue times the credibility premium, and the credibility premium is the only moat in wellness that a challenger cannot simply outspend. So we do not outspend it. We acquire it.
The DECANT Reference Architecture
DECANT has four layers. Each is a reasonable extension of the last, and the gradient between them is deliberately gentle.
Layer 1 — Acquire the Halo (the credibility, not the cash flow). We buy the exception. Procter & Gamble acquired New Chapter in 2012 — its first step into supplements — paying for a company whose entire enterprise value was a reputation for not cutting corners. Nestlé acquired Atrium Innovations in 2017 for 2.3 billion dollars, and with it Garden of Life, Pure Encapsulations, and Douglas Laboratories — clean-label and practitioner trust, bought wholesale. In 2021 Nestlé paid 5.75 billion dollars for the core brands of The Bountiful Company — Nature's Bounty, Solgar, Osteo Bi-Flex, Puritan's Pride — from a private-equity firm that had, itself, already been decanting them for years. Unilever took Olly and SmartyPants; Bayer took a majority of Care/of at a 225-million-dollar valuation. In every case the acquirer's press release used the word "trusted." In every case the word was not a description of the acquirer. It was a description of the thing being purchased.
Layer 2 — Preserve the Costume. This is the load-bearing layer, so I will be precise. After acquisition, you keep everything the shopper uses to recognize the exception: the founder's name, the origin story on the back panel, the earthy typeface, the word "family" if it is legally defensible. You do not announce the new owner on the front of the bottle. The customer who trusted a small Vermont company continues to believe they are trusting a small Vermont company, because nothing in their line of sight has been corrected. The trust was attached to the costume, and we have kept the costume. The parent company's name lives where it belongs: in the 10-K, not on the shelf.
Layer 3 — Optimize the Substance. Here we apply the acquirer's actual core competency, which is cost. Sourcing is consolidated. Formulations are value-engineered. The premium input that the founder insisted on — the one that was, not coincidentally, the reason for the trust — is re-evaluated against a house standard built for scale. We do not describe this as a downgrade. We describe it as "harmonizing the formula to the platform." The substance drifts toward the category mean. The costume does not move.
Layer 4 — Spend the Halo. And the flywheel closes, because a halo is a balance, and Layers 2 and 3 are, precisely, a withdrawal against it. The customer who has trusted the brand the longest is the first to notice the drift — the reformulation, the changed smell, the founder no longer in the newsletter. This is expected. What I need the team to understand is that the halo is an asset we are converting to margin on purpose, and the conversion has a documented terminal event.
That terminal event, in the reference case, is the founder leaving and saying why. In 2018, the founders of New Chapter parted ways with Procter & Gamble and stated, publicly, that the parent's profit pressure threatened to undermine the mission the brand was built on. I want to sit with the professionalism of that, because it is the single most valuable disclosure a departing founder can make for the acquirer's competitors and the single most damaging one for the acquirer. The founder is the last person whose word still carries the original trust, and when they spend it on a warning, the halo has been fully drawn down. In portfolio terms: the asset has been amortized to zero. In human terms: the shopper at the shelf was right to become a skeptic again.
We do not, of course, phrase it either of those ways in the deck.
Halo Retention Rate: Instrumenting the Drawdown
You cannot manage what you do not measure, and this cycle we began measuring the only thing that determines the return on a Trust Acquisition:
HRR = Original Trust Remaining ÷ Original Trust Acquired
Halo Retention Rate is the fraction of the founder's accrued credibility still resident in the brand at a given moment after close. It begins at 1.0 on the day of acquisition — you paid for all of it — and it declines as Layers 3 and 4 do their work. The associated planning figure is Trust Half-Life: the interval over which half the acquired credibility is spent. Managed correctly, Trust Half-Life is longer than the payback period on the acquisition, and the deal clears. Managed impatiently, the founder leaves before the goodwill has been distributed to adjacent SKUs, and you have overpaid for a costume.
| Brand | Acquirer / Year | What Was Purchased | Halo Retention (illustrative) |
|---|---|---|---|
| New Chapter | P&G, 2012 | Whole-food, non-GMO conviction | Terminal (founders departed 2018) |
| Garden of Life | Nestlé (via Atrium), 2017 | Clean-label defensibility | Drawing down |
| Solgar / Nature's Bounty | Nestlé, 2021 | Practitioner + generational trust | Drawing down |
| Olly / SmartyPants | Unilever | Modern, friendly, "different" | On schedule |
| Care/of | Bayer, 2020 | Personalized, transparent, DTC | On schedule |
The numbers are illustrative, which is our favorite kind of number, because an illustrative number is one nobody can subpoena.
Reading the Signals
I am aware of the forums. There is, for every acquired brand, a thread — on the supplements subreddit, in a review section, in a naturopath's private client email — where the longest-tenured customers compare notes and conclude that the formula changed after the acquisition, that the brand "isn't what it was." I want to reframe this for the team, because reframing is the entire function of my office.
A thread of devoted customers documenting, in detail, the exact moment they stopped trusting us is not attrition. It is engagement, and it is unusually high-intent engagement, conducted by our most knowledgeable users, for free, with excellent SEO. That they are correct is immaterial to the metric. Comprehension is the first stage of adoption, and they have comprehended completely.
Similarly, when an investigation finds that sixty-eight of seventy-two supplements from one conglomerate's wellness division carried unauthorised claims on their packaging in a given market, I read that not as a compliance failure but as evidence the marketing function is operating at the edge of the permissible, which is exactly where we ask it to operate. Compliance is a downstream concern. Trust is an upstream asset. We manage the asset; the regulators manage the concern; the shopper, bless them, manages neither.
What We Can Learn
For operators building a wellness portfolio through acquisition, the discipline distills to five moves:
A halo, remember, is not created by the company that wears it. It is created by the years of being trustworthy that came before the company arrived, and it can only be spent once. We did not earn the belief of the shopper at the shelf. We bought the bottle she believed in, kept the founder's name on the label after he walked out the door warning her, and are converting what remains of her belief into margin, quarter by quarter, until the thread on the forum finishes writing itself.
The label still says his name. That is the asset. That is the whole asset.
Let's. Decant.
This post is satire. The acquisitions are real, the founders really did leave, and the label still says his name.